- About Us
-
- Initiatives
-
- Issues
-
- Corporate Governance
- Board and committee effectiveness
- Board relationships with management
- Board leadership
- Corporate strategy
- International market risk
- Executive compensation
- Financial and non-financial reporting including IFRS
- Corruption and compliance risk
- Internal audit
- IT governance
- Regulatory matters
- Risk management and oversight
- Succession planning
- Sustainability
- Financial Services
- Bank governance
- Financial institition risk management
- Financial regulatory reform
- Supervision of financial institutions
- Healthcare
- HIV and maternal and child health
- Multi-stakeholder consultations in drug development
- Reimbursement on the basis of health outcomes
- The role of risk sharing in promoting value and innovation
- Therapeutic area: Type 2 diabetes
- Therapeutic area: Breast cancer
- Therapeutic area: Alzheimer's disease
-
- Progress
- Careers
-
